Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hutchison China Meditech

15.10
-0.2400-1.56%
Post-market: 15.100.00000.00%16:04 EDT
Volume:36.92K
Turnover:556.92K
Market Cap:2.63B
PE:75.50
High:15.28
Open:15.10
Low:14.86
Close:15.34
Loading ...

Is Tenaya Therapeutics, Inc. (TNYA) the Cheapest Stock Insiders Are Buying In March?

Insider Monkey
·
28 Mar

Evisort AI-Powered Contract Intelligence Now Available Through Workday

PR Newswire
·
27 Mar

Rimini Street Launches Rimini Manage™ for Workday

Business Wire
·
27 Mar

Infosys Powers LKQ Europe's HR Transformation with a Unified Digital Platform

PR Newswire
·
27 Mar

Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Results from Phase 2 CIRRUS-HCM 28-Day Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) on Wednesday, April 2 at 8:30 am Eastern Time

PR Newswire
·
27 Mar

HCM II Acquisition to Merge With Next-Generation Nuclear Reactor Company; Shares Climb

MT Newswires Live
·
26 Mar

Paychex sees Paycor HCM acquisition to be accretive to adjusted EPS next FY

TIPRANKS
·
26 Mar

HCM II Acquisition Corp trading resumes

TIPRANKS
·
26 Mar

HCM II Acquisition Corp. Announces Terrestrial Energy Merger

TIPRANKS
·
26 Mar

Terrestrial Energy to become publicly traded via HCM II Acquisition combination

TIPRANKS
·
26 Mar

Terrestrial Energy to Become First Publicly Traded Molten Salt Nuclear Reactor Developer Through Combination with HCM II Acquisition Corp.

GlobeNewswire
·
26 Mar

Asure Software Strengthens Innovation Leadership through Strategic AI Partnership with AWS

GlobeNewswire
·
26 Mar

3 Stocks Estimated To Be Trading At A Discount Of 25.2% To 28.2%

Simply Wall St.
·
25 Mar

Workday Named a Leader in 2025 Gartner® Magic Quadrant™ for Higher Education Student Information Systems

PR Newswire
·
24 Mar

AI Becoming Essential to HCM, ISG Says

Business Wire
·
21 Mar

Hutchmed Receives Conditional Approval for Tazverik as Follicular Lymphoma Treatment in China

MT Newswires Live
·
21 Mar

HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma

GlobeNewswire
·
21 Mar

Poxel Announces Positive Results from a Preclinical Study for PXL065, a Proprietary Deuterium-Stabilized R-Stereoisomer of Pioglitazone, in Hypertrophic Cardiomyopathy

Business Wire
·
21 Mar

HUTCHMED (China) Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
20 Mar

Cytokinetics announces launch of EARTH-HCM

TIPRANKS
·
20 Mar